To investigate the effect of fractionated whole-brain irradiation on nonhuman primates, 6–9-year-old male rhesus monkeys were irradiated with 40 Gy delivered as two 5-Gy fractions/week for 4 weeks. Cognitive function was assessed 5 days/week for 4 months prior to fractionated whole-brain irradiation and for 11 months after irradiation using a Delayed-Match-to-Sample (DMS) task at both low and high cognitive loads. Local rates of cerebral glucose metabolism were measured prior to and 9 months after irradiation using [18F]-2-deoxy-2-fluoro-d-glucose positron emission tomography. Low cognitive load trials did not reveal a significant reduction in performance until 7 months after irradiation; performance then declined progressively. In high cognitive load trials, the initial impairment was observed ∼1 month after irradiation. This was followed by a transient recovery period over the next 1–2 months, after which performance declined progressively through 11 months after irradiation. Nine months after irradiation, glucose uptake during the DMS task was decreased in the cuneate and prefrontal cortex and was increased in the cerebellum and thalamus compared with the levels prior to irradiation. Results from this pilot study suggest that the radiation-induced changes in cognition and brain metabolism observed in rhesus monkeys may be similar to those observed in brain tumor patients receiving brain irradiation.
Skip Nav Destination
Close
Article navigation
1 April 2011
Research Article|
January 28 2011
A Model for Assessing Cognitive Impairment after Fractionated Whole-Brain Irradiation in Nonhuman Primates
Mike E Robbins
;
Mike E Robbins
1
a Department of Radiation Oncology, Wake Forest University School of Medicine, Winston-Salem, North Carolina 27157
e Brain Tumor Center of Excellence, Wake Forest University School of Medicine, Winston-Salem, North Carolina 27157
1 Address for correspondence: Room 412C NRC, Department of Radiation Oncology, Wake Forest University School of Medicine, Medical Center Blvd., Winston-Salem, NC 27157; e-mail: mrobbins@wfubmc.edu.
Search for other works by this author on:
J. Daniel Bourland
;
J. Daniel Bourland
a Department of Radiation Oncology, Wake Forest University School of Medicine, Winston-Salem, North Carolina 27157
e Brain Tumor Center of Excellence, Wake Forest University School of Medicine, Winston-Salem, North Carolina 27157
Search for other works by this author on:
J. Mark Cline
;
J. Mark Cline
d Section of Comparative Medicine, Wake Forest University School of Medicine, Winston-Salem, North Carolina 27157
Search for other works by this author on:
Kenneth T Wheeler
;
Kenneth T Wheeler
b Department of Radiology, Wake Forest University School of Medicine, Winston-Salem, North Carolina 27157
e Brain Tumor Center of Excellence, Wake Forest University School of Medicine, Winston-Salem, North Carolina 27157
Search for other works by this author on:
Sam A Deadwyler
Sam A Deadwyler
c Department of Physiology & Pharmacology, Wake Forest University School of Medicine, Winston-Salem, North Carolina 27157
e Brain Tumor Center of Excellence, Wake Forest University School of Medicine, Winston-Salem, North Carolina 27157
Search for other works by this author on:
Radiat Res (2011) 175 (4): 519–525.
Article history
Received:
November 11 2010
Accepted:
November 29 2010
Citation
Mike E Robbins, J. Daniel Bourland, J. Mark Cline, Kenneth T Wheeler, Sam A Deadwyler; A Model for Assessing Cognitive Impairment after Fractionated Whole-Brain Irradiation in Nonhuman Primates. Radiat Res 1 April 2011; 175 (4): 519–525. doi: https://doi.org/10.1667/RR2497.1
Download citation file:
Close
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Sign in via your Institution
Sign in via your InstitutionCiting articles via
Commonalities Between COVID-19 and Radiation Injury
Carmen I. Rios, David R. Cassatt, Brynn A. Hollingsworth, Merriline M. Satyamitra, Yeabsera S. Tadesse, Lanyn P. Taliaferro, Thomas A. Winters, Andrea L. DiCarlo
Low-Dose Radiation Therapy (LDRT) for COVID-19: Benefits or Risks?
Pataje G. Prasanna, Gayle E. Woloschak, Andrea L. DiCarlo, Jeffrey C. Buchsbaum, Dörthe Schaue, Arnab Chakravarti, Francis A. Cucinotta, Silvia C. Formenti, Chandan Guha, Dale J. Hu, Mohammad K. Khan, David G. Kirsch, Sunil Krishnan, Wolfgang W. Leitner, Brian Marples, William McBride, Minesh P. Mehta, Shahin Rafii, Elad Sharon, Julie M. Sullivan, Ralph R. Weichselbaum, Mansoor M. Ahmed, Bhadrasain Vikram, C. Norman Coleman, Kathryn D. Held
Germicidal Efficacy and Mammalian Skin Safety of 222-nm UV Light
Manuela Buonanno, Brian Ponnaiya, David Welch, Milda Stanislauskas, Gerhard Randers-Pehrson, Lubomir Smilenov, Franklin D. Lowy, David M. Owens, David J. Brenner